ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

October 13, 1989

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics

May 4, 1990

NCI, Private Groups, Promote Mammograms To Blacks, Hispanics

April 25, 1992

Lasker Awards Announced

September 25, 2009

In Brief: 163 PIs Hold Both Contracts, Grants; Hopkins Scientists Questions Retrospective Diet Studies

August 27, 1976